Advanced Prostate Cancer: PSMA-Targeted Radioligand Therapies

EP. 1: Prostate Cancer Disease Complexity and Testing

July 23rd 2021

Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies.

EP. 2: Genotypic and Phenotypic Biomarkers in Prostate Cancer

July 23rd 2021

A discussion of phenotypic and genotypic biomarkers found in prostate cancer and their implications.

EP. 3: Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer

July 28th 2021

An overview of the diagnostic and therapeutic applications of PSMA in prostate cancer is presented.

EP. 4: Use of PSMA PET Scans in Advanced Prostate Cancer

July 30th 2021

Dr Neal Shore explains the clinical implications of PSMA PET scans in advanced prostate cancer.

EP. 5: The VISION Study of 177Lu-PSMA-617 in mCRPC

August 6th 2021

Results of the phase 3 VISION study of 177Lu-PSMA PET in advanced prostate cancer are described.

EP. 6: Future Directions With PSMA Ligand–Directed Therapies

August 6th 2021

Highlights of potential future applications of PSMA ligand–directed therapies in prostate cancer.